In the BioHarmony Drug Report Database
Mecamylamine
Inversine (mecamylamine) is a small molecule pharmaceutical. Mecamylamine was first approved as Inversine on 1982-01-01. It is used to treat malignant hypertension and tourette syndrome in the USA. The pharmaceutical is active against neuronal acetylcholine receptor subunit alpha-3. In addition, it is known to target neuronal acetylcholine receptor subunit alpha-4, neuronal acetylcholine receptor subunit alpha-2, acetylcholine receptor subunit alpha, neuronal acetylcholine receptor subunit alpha-6, and neuronal acetylcholine receptor subunit alpha-7.
Trade Name
|
Inversine |
|---|---|
Common Name
|
mecamylamine |
ChEMBL ID
|
CHEMBL267936 |
Indication
|
malignant hypertension, tourette syndrome |
Drug Class
|
Image (chem structure or protein)